TBPH: Theravance Biopharma Inc Company Profile & Statistics

About

Theravance Biopharma is a biopharmaceutical company primarily focused on discovering, developing and commercializing respiratory medicines. The company was formed following the split of the erstwhile Theravance into two listed companies in June 2014 - Innoviva, Inc. (then Theravance, Inc.) and Theravance.?

Info & Links

CEO

Rick E Winningham

Headquarters

901 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO, CA 94080, CAYMAN ISLANDS

Auditor

Ernst & Young LLP

Share holders

Employees

Theravance Biopharma Inc Statistics

Valuation Measures

Market Capitalization²

495.14M

Enterprise Value

471.76M

Enterprise Value/EBITDA(ttm)

-10.62

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

7.69

Price to Book(mrq)

2.60

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-78.18%

Profit Margin(ttm)

-80.02%

Return on Equity(ttm)

-24.79%

Return on Invested Capital(ttm)

-25.06%

Return on Assets(ttm)

-13.43%

Income Statement

Revenue(ttm)

63.19M

Revenue Per Share(ttm)

1.29

Gross Profit(ttm)

63.19M

EBITDA(ttm)³

-44.44M

Net Income Available to Common(ttm)

-49.40M

Diluted EPS(ttm)

-1.01

Share Statistics

Beta (5Y Monthly)

0.23

52-Week Change

-6.41%

S&P 500 52-Week Change

27.84%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

49.17M

Dividend Yield

0.00%

Float⁴

45.78M

% Held by Insiders

6.90%

% Held by Institutions

99.10%

Balance Sheet

Total Cash(mrq)

91.36M

Total Cash Per Share(mrq)

1.86

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.97%

Quick Ratio(mrq)

4.97%

Book Value Per Share(mrq)

3.78

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.22

Free Cash Flow(ytd)

-10.78M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

TBPH

Theravance Biopharma Inc

Theravance Biopharma Inc Profile